Shigella antigen-specific B memory cells are associated with decreased disease severity in subjects challenged with wild-type Shigella flexneri 2a-Reference-Cited by-同舟云学术

Shigella antigen-specific B memory cells are associated with decreased disease severity in subjects challenged with wild-type Shigella flexneri 2a

Published:2013-07 Issue:1 Volume:148 Page:35-43
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Wahid Rezwanul,Simon Jakub K.,Picking Wendy L.,Kotloff Karen L.,Levine Myron M.,Sztein Marcelo B.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference39 articles.

1. A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology;von Seidlein;PLoS Med.,2006

2. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies;Kotloff;Bull. World Health Organ.,1999

3. Antimicrobial resistance among enteric pathogens;Pickering;Semin. Pediatr. Infect. Dis.,2004

4. Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road;Levine;Nat. Rev. Microbiol.,2007

5. Genotypic and phenotypic characterization of an aroD deletion-attenuated Escherichia coli K12-Shigella flexneri hybrid vaccine expressing S. flexneri 2a somatic antigen;Newland;Vaccine,1992

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of cellular effectors in the induction and maintenance of IgA responses leading to protective immunity against enteric bacterial pathogens;Frontiers in Immunology;2024-09-11

2. The use of controlled human infection models to identify correlates of protection for invasive Salmonella vaccines;Frontiers in Immunology;2024-08-27

3. B memory cell responses to LPS, IVP and IpaB antigen after oral vaccination with Shigella sonnei vaccine candidates WRSs2 and WRSs3;PLOS ONE;2024-01-17

4. Shigella virulence protein VirG is a broadly protective antigen and vaccine candidate;npj Vaccines;2024-01-02

5. Further characterization of Shigella-specific (memory) B cells induced in healthy volunteer recipients of SF2a-TT15, a Shigella flexneri 2a synthetic glycan-based vaccine candidate;Frontiers in Immunology;2023-10-31